Growth Metrics

Astrana Health (ASTH) Change in Receivables (2016 - 2025)

Astrana Health (ASTH) has disclosed Change in Receivables for 16 consecutive years, with $10.4 million as the latest value for Q1 2025.

  • Quarterly Change in Receivables fell 60.32% to $10.4 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$40.4 million through Mar 2025, down 298.94% year-over-year, with the annual reading at -$2.3 million for FY2025, 90.84% up from the prior year.
  • Change in Receivables hit $10.4 million in Q1 2025 for Astrana Health, up from -$62.6 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $52.6 million in Q2 2022 to a low of -$62.6 million in Q4 2024.
  • Historically, Change in Receivables has averaged -$24235.3 across 5 years, with a median of $711000.0 in 2021.
  • Biggest YoY gain for Change in Receivables was 1520.18% in 2022; the steepest drop was 3505.63% in 2022.
  • Year by year, Change in Receivables stood at -$9.2 million in 2021, then plummeted by 338.31% to -$40.2 million in 2022, then surged by 36.06% to -$25.7 million in 2023, then plummeted by 143.63% to -$62.6 million in 2024, then soared by 116.56% to $10.4 million in 2025.
  • Business Quant data shows Change in Receivables for ASTH at $10.4 million in Q1 2025, -$62.6 million in Q4 2024, and $35.5 million in Q3 2024.